Real-world evidence for a prescription digital therapeutic to treat opioid use disorder.

Yuri A MaricichXiaorui XiongRobert GerwienAlice KuoFulton F VelezBruce ImbertKeely BoyerHilary F LudererStephen BraunKarren Williams

Published in: Current medical research and opinion (2020)

Results demonstrate that reSET-O is readily and broadly used by patients with OUD and that high real-world engagement with the therapeutic is positively associated with abstinence and retention in treatment. ReSET-O is a potentially valuable adjunct to buprenorphine MOUD therapy for patients with OUD.

Keyphrases

social media
smoking cessation